These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10561676)

  • 1. The effects on ovarian activity of a monophasic oral contraceptive with 100 microg levonorgestrel and 20 microg ethinyl estradiol.
    Coney P; DelConte A
    Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):53-8. PubMed ID: 10561676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 microg levonorgestrel and 20 microg ethinyl estradiol (Alesse). North american Levonorgestrel Study Group (NALSG).
    Archer DF; Maheux R; DelConte A; O'Brien FB
    Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):39-44. PubMed ID: 10561674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of low-dose monophasic levonorgestrel with ethinyl estradiol preparation on serum lipid levels: A twenty-four month clinical trial.
    Young RL; DelConte A
    Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):59-62. PubMed ID: 10561677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of a low-dose monophasic preparation of levonorgestrel and ethinyl estradiol on coagulation and other hemostatic factors.
    Archer DF; Mammen EF; Grubb GS
    Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):63-6. PubMed ID: 10561678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter randomized comparison of cycle control and laboratory findings with oral contraceptive agents containing 100 microg levonorgestrel with 20 microg ethinyl estradiol or triphasic norethindrone with ethinyl estradiol.
    Reisman H; Martin D; Gast MJ
    Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):45-52. PubMed ID: 10561675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian activity suppression by two different low-dose triphasic oral contraceptives.
    van der Does J; Exalto N; Dieben T; Bennink HC
    Contraception; 1995 Dec; 52(6):357-61. PubMed ID: 8749599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alesse: leading the shift to 20 microg.
    Archer DF
    Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):37-8. PubMed ID: 10561673
    [No Abstract]   [Full Text] [Related]  

  • 8. Using a low-dose contraceptive in women 35 years of age and over: 20 microg estradiol/100 microg levonorgestrel.
    Carr BR; DelConte A
    Contraception; 2002 Jun; 65(6):397-402. PubMed ID: 12127636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International clinical experience with a new low-dose, monophasic oral contraceptive containing levonorgestrel 100 microg and ethinyl estradiol 20 microg.
    Boerrigter PJ; Ellman H; Dolker M
    Clin Ther; 1999 Jan; 21(1):118-27. PubMed ID: 10090429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 microg) and ethinyl estradiol (15 microg) on ovarian activity.
    Sullivan H; Furniss H; Spona J; Elstein M
    Fertil Steril; 1999 Jul; 72(1):115-20. PubMed ID: 10428158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of ovulation by an oral contraceptive containing 100 micrograms levonorgestrel in combination with 20 micrograms ethinylestradiol.
    Spona J; Feichtinger W; Kindermann C; Wünsch C; Brill K
    Contraception; 1996 Nov; 54(5):299-304. PubMed ID: 8934064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of a new low-dose combined oral contraceptive containing levonorgestrel on ovarian activity.
    Teichmann A; Martens H; Bordasch C; Petersen G; Lorkowski G
    Eur J Contracept Reprod Health Care; 1996 Sep; 1(3):245-56. PubMed ID: 9678123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of tolterodine on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive containing ethinyl estradiol and levonorgestrel.
    Olsson B; Landgren BM
    Clin Ther; 2001 Nov; 23(11):1876-88. PubMed ID: 11768839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of ovarian follicular activity during treatment with a monthly injectable contraceptive and a low-dose oral contraceptive.
    Jain JK; Ota F; Mishell DR
    Contraception; 2000 Mar; 61(3):195-8. PubMed ID: 10827333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian function with the contraceptive vaginal ring or an oral contraceptive: a randomized study.
    Duijkers IJ; Klipping C; Verhoeven CH; Dieben TO
    Hum Reprod; 2004 Nov; 19(11):2668-73. PubMed ID: 15333593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal treatment for bleeding irregularities in Norplant implant users.
    Alvarez-Sanchez F; Brache V; Thevenin F; Cochon L; Faundes A
    Am J Obstet Gynecol; 1996 Mar; 174(3):919-22. PubMed ID: 8633669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian function during treatment with high ratio levonorgestrel/ethinyl estradiol as oral contraceptives.
    Johansson ED; Elamsson K; Elmestedt U
    Gynecol Obstet Invest; 1982; 14(2):97-105. PubMed ID: 6811379
    [No Abstract]   [Full Text] [Related]  

  • 18. Ovarian activity in women taking an oral contraceptive containing 20 microg ethinyl estradiol and 150 microg desogestrel: effects of low estrogen doses during the hormone-free interval.
    Killick SR; Fitzgerald C; Davis A
    Am J Obstet Gynecol; 1998 Jul; 179(1):S18-24. PubMed ID: 9704814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
    Carlström K; Lunell NO; Zador G
    Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinyl estradiol.
    Bjarnadóttir RI; Tuppurainen M; Killick SR
    Am J Obstet Gynecol; 2002 Mar; 186(3):389-95. PubMed ID: 11904596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.